These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4357905)

  • 1. [Investigation of poliovirus neutralizing antibody level in nurse students].
    Otatsume S; Kinebuchi H
    Kansenshogaku Zasshi; 1973 Aug; 47(8):275-82. PubMed ID: 4357905
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistence of poliovirus neutralizing antibodies eight years after immunization with live, attenuated-virus vaccine.
    Rousseau WE; Noble GR; Tegtmeier GE; Jordan MC; Chin TD
    N Engl J Med; 1973 Dec; 289(25):1357-9. PubMed ID: 4356637
    [No Abstract]   [Full Text] [Related]  

  • 3. Poliovirus antibody status after vaccination with trivalent oral vaccine.
    Clara R; Deprettere A; van der Berghe D; Pattyn S
    Acta Paediatr Belg; 1976; 29(4):245-51. PubMed ID: 192040
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of poliovirus neutralizing antibodies in young adult women.
    Mayer TR; Balfour HH
    JAMA; 1981 Sep; 246(11):1207-9. PubMed ID: 6267329
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan.
    Iwai M; Nakayama T; Matsuura K; Hasegawa S; Ando S; Obara M; Nagai Y; Yoshida H; Horie H
    Acta Virol; 2006; 50(2):139-43. PubMed ID: 16808333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poliovirus antibodies in age groups: an assessment of obligatory vaccination in Belgium.
    Lamy ME; Cornu C; Desmyter J
    Dev Biol Stand; 1979; 43():207-13. PubMed ID: 230111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan.
    Iwai M; Takizawa T; Nakayama T; Matsuura K; Yoshida H; Hasegawa S; Obara M; Horimoto E; Kurata T; Horie H
    Scand J Infect Dis; 2008; 40(3):247-53. PubMed ID: 17907043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of poliovirus antibody titers in orally vaccinated semi-captive chimpanzees in Uganda.
    Mugisha L; Pauli G; Opuda-Asibo J; Joseph OO; Leendertz FH; Diedrich S
    J Med Primatol; 2010 Apr; 39(2):123-8. PubMed ID: 20102460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody titers to polioviruses in patients ten years after immunization with sabin vaccine.
    Sanders DY; Cramblett HG
    J Pediatr; 1974 Mar; 84(3):406-8. PubMed ID: 4359799
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neutralizing antibodies to poliovirus in the sera of newborn infants before and after mass immunization of the Brazilian population from 0 to 5. São Paulo, Brazil (1980)].
    Hutzler RU; Fujita M; Waldman EA; Ayub MA; Ferrari FL; Pinto PR; Cury PC; Kim JS; Matheus JG
    Rev Inst Med Trop Sao Paulo; 1984; 26(2):78-82. PubMed ID: 6089300
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference.
    John TJ; Jayabal P
    Am J Epidemiol; 1972 Oct; 96(4):263-9. PubMed ID: 4342327
    [No Abstract]   [Full Text] [Related]  

  • 12. The response to oral poliovaccine in persons aged 16-18 years.
    Smith JW; Lee JA; Fletcher WB; Morris CA; Parker DA; Yetts R; Magrathe DI; Perkins FT
    J Hyg (Lond); 1976 Apr; 76(2):235-47. PubMed ID: 177700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poliovirus antibody differentiation. Methods and application for strain specific diagnosis in complications after oral vaccination.
    Kuwert E; Höher PG; Thraenhart O
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):407-12. PubMed ID: 180727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serosurvey for polio antibodies.
    Biberi-Moroeanu S; Munţiu A; Stoiculescu S
    Virologie; 1988; 39(4):241-5. PubMed ID: 2851206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neutralizing antibodies in the sera of persons vaccinated with intradermal poliovirus vaccine].
    Jarzabek Z; Kańtoch M
    Przegl Epidemiol; 1984; 38(3):323-6. PubMed ID: 6098935
    [No Abstract]   [Full Text] [Related]  

  • 17. [Stage of immunity to Poliovirus type 1 and 3 in adult women and in newborn infants: study of comparative efficiency of 2 methods for determination of neutralizing antibodies].
    Barbi M
    Ann Sclavo; 1972; 14(6):694-704. PubMed ID: 4360238
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum antibody to poliovirus in patients in a mental deficiency hospital, with particular reference to Down's syndrome.
    McKay E; Hems G; Massie A; Moffat MA; Phillips KM
    J Hyg (Lond); 1978 Aug; 81(1):25-30. PubMed ID: 211162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-lasting poliovirus-neutralizing antibodies among Argentinean population immunized with four or five oral polio vaccine doses 1 month to 19 years previously.
    Nates SV; Martinez LC; Barril PA; Ferreyra LJ; Giordano MO; Masachessi G; Isa MB
    Viral Immunol; 2007; 20(1):3-10. PubMed ID: 17425416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of poliovirus-neutralizing antibodies 2-16 years after immunization with live attenuated vaccine. A seroepidemiologic survey in the mainland of Venice.
    Trivello R; Renzulli G; Farisano G; Bonello C; Moschen M; Gasparini V; Benussi G
    Epidemiol Infect; 1988 Dec; 101(3):605-9. PubMed ID: 2850939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.